[Validity of "Gravistat" device for the improvement of statics and locomotion: interrelation with neuro-auto-immune reactions].
The purpose was to study the interrelation between effectiveness of the dynamic proprioceptive correction (DPC) of static and locomotor disorders at the late residual phase of children's cerebral paralysis (CCP) with the help of "Gravistat" and the auto-immune reactions (AIR) to neurospecific proteins (NSP). Data of an original method of AIR evaluation by the ratio of IgC to proteins S-100 and alpha-2-glycoprotein in blood serum make it evident that the method can pinpoint events in the perinatal period (3.5-18 yrs.) both in healthy individuals and patients with residual CCP. In addition, the method can predict efficiency of the DPC therapy of CCP and, probably, cerebral circulation disturbances, craniocerebral injury, and other conditions with a neuro-autoimmune component.